Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients. The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T‑cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
Contributions
Contributors
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
